IVIG--mechanisms of action.

Simon HU; Späth PJ

doi:10.1034/j.1398-9995.2003.00239.x

Back

Journal article

IVIG--mechanisms of action.

Simon HU Department of Pharmacology, University of Bern, Switzerland; ZLB Bioplasma AG, Bern, Switzerland.
Späth PJ

2003-06-26

Published in:

Allergy. - 2003

Common Variable Immunodeficiency

English Intravenous immunoglobulin (IVIG) preparations are fractionated from a plasma pool of several thousand donors. IVIG contain immune antibodies and physiologic autoantibodies. Immune antibodies reflect the immunologic experience of the donor population. This fraction of IVIG preparations is useful for replacement therapy and passive immunisation. Natural autoantibodies are able to react with the immune system of the recipient of IVIG and are suggested to help to correct immune deregulation. Immunomodulatory and anti-inflammatory properties are based on multiple mechanisms of action which are described. These mechanisms are effective concomitantly and synergistically at every occasion of use of IVIG in inflammatory and autoimmune disorders.

Language